CurcumaSorb

• Helps relieve joint inflammation and associated symptoms such as joint pain when used in conjunction with conventional treatment
• Provides antioxidants for the maintenance of good health
• Clinically studied for enhanced absorption
• Made with vegan ingredients

CurcumaSorb provides the patented Meriva^® curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine in a 1:2 ratio, promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20 times greater with Meriva^® than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva^® were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva^® per day helped relieve joint inflammation and provided significant benefit in joint comfort, mobility and quality of life when used in conjunction with conventional treatment.